Urology Today.net

Site updated at Thursday, 18 December 2014

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



genetic predisposition1 - membranous nephropathy3 - urethral stones1 - human vaccine1 - painful urination1 - turner syndrome3 - foley catheters1 - upper urinary tract2 - zetia1 - stones etiology3 - ecm1 - cprs-r1 - joslin diabetes center1 - avandia1 - urinary incontinence22 - end-stage kidney disease3 - suspected fistula1 - protein in the urine2 - benign prostate tissue1 - prostate-specific antigen screening1 - adequate erection1 - constipation3 - urinary ph1 - biopsy outcome1 - primary care1 - end-stage kidney failure2 - body mass index2 - percutaneous nephrolithotomy1 - university of michigan medical school in ann arbor1 - α-hemolysin1 -